SILO_LOGO_A.png
Silo Pharma Enters into Sponsored Research Agreement with Columbia University to Develop Psychedelic Therapeutics for Alzheimer’s Disease
October 27, 2021 08:15 ET | SILO PHARMA INC.
Englewood Cliffs, NJ, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO), a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today...
STUDY: PLUNGE IN EMISSIONS DURING SHUTDOWN DEMONSTRATES POTENTIAL FOR HUGE ENVIRONMENTAL, HEALTH, AND ECONOMIC GAINS
December 21, 2020 14:41 ET | Abt Associates
Rockville, Md., Dec. 21, 2020 (GLOBE NEWSWIRE) -- A new study from Columbia University, Abt Associates, and ZevRoss Spatial Analysis finds that New York City’s two-month shutdown during...
Sakıp Sabancı International Research Awards Jury Prize Was Given to Prof. Joseph S. Nye, Jr.
April 22, 2019 09:30 ET | Sabancı University
Istanbul, April 22, 2019 (GLOBE NEWSWIRE) -- In honor of the late Sakıp Sabancı (1933-2004), a philanthropist and businessman who transformed family business into one of the largest conglomerates in...
BioDelivery Sciences logo
BioDelivery Sciences to Report Third Quarter 2018 Financial Results on November 8, 2018
October 23, 2018 08:00 ET | BioDelivery Sciences International, Inc.
RALEIGH, N.C., Oct. 23, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial stage specialty pharmaceutical company dedicated to patients...
BioDelivery Sciences logo
BioDelivery Sciences to Host Institutional Investor and Analyst Day on Friday, October 5, 2018
September 13, 2018 07:30 ET | BioDelivery Sciences International, Inc.
RALEIGH, N.C., Sept. 13, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial stage specialty pharmaceutical company dedicated to patients...
BioDelivery Sciences logo
BioDelivery Sciences to Present at the 2018 Janney Montgomery Scott Healthcare Conference
September 10, 2018 08:00 ET | BioDelivery Sciences International, Inc.
RALEIGH, N.C., Sept. 10, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI), a leading commercial stage specialty pharmaceutical company dedicated to patients living...
BioDelivery Sciences logo
BioDelivery Sciences to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
August 21, 2018 08:00 ET | BioDelivery Sciences International, Inc.
RALEIGH, N.C., Aug. 21, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc., (NASDAQ:BDSI), a leading commercial specialty pharmaceutical company dedicated to patients living with...
BioDelivery Sciences logo
BioDelivery Sciences to Report Second-Quarter 2018 Financial Results on August 9, 2018
July 24, 2018 16:30 ET | BioDelivery Sciences International, Inc.
RALEIGH, N.C., July 24, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI) today announced that it will report its second quarter 2018 financial results after the close...
LuxuryInstitute_logo_tag[1].png
Luxury Institute Launches Emotionally Intelligent Brand Index Survey with Radically New and Disruptive Metrics to Measure Brand Equity and Customer Loyalty
June 05, 2018 08:00 ET | Luxury Institute
NEW YORK, June 05, 2018 (GLOBE NEWSWIRE) -- The independent and objective New York-based Luxury Institute today announced its new and groundbreaking Emotionally Intelligent Brand Index (EIBI),...
Altair_Brandmark_Hz_RGB_FullColor.jpg
Mary C. Boyce, Dean of Engineering at Columbia University, Joins Altair Board
April 03, 2018 16:05 ET | Altair Engineering Inc.
TROY, Mich., April 03, 2018 (GLOBE NEWSWIRE) -- Dean Mary C. Boyce has accepted an appointment to the Altair (Nasdaq:ALTR) Board of Directors.  She is Dean of The Fu Foundation School of Engineering...